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INTRODUCTION
Circadian rhythms are intracellular programs that generate self-
sustained oscillations approximately every 24 hours [1]. Circadi-
an rhythmicity is controlled by the circadian transcription factors 
(circadian locomotor output cycles kaput, period, cryptochrome 
circadian clock, and brain and muscle ARNT-like 1), which are 
driven by internal central and peripheral clocks [2]. These clocks 
may also be regulated by many environmental signals, such as 
temperature, food intake, and social interaction [3] and are dif-
ferentially controlled by light/dark signals among individuals [4]. 
Circadian preferences in the timing of sleeping and waking (called 
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chronotypes) vary from extreme “larks” to extreme “owls” [4]. In-
dividuals with an early chronotype (larks) wake up easily in the 
morning and have difficulty staying awake late at night [5]. Con-
versely, those with a late chronotype (owls) sleep later and have 
trouble waking in the early morning [5]. In industrialized societ-
ies, most of the population is scheduled to work at the same time, 
commonly beginning in the morning. As a result, late chrono-
types experience significant shifts in sleep time between work days 
and free days due to social obligations [6]. This discrepancy be-
tween an individual’s work time and social time is known as “so-
cial jetlag” (SJL) [5,7], which reflects a circadian misalignment [8].
Sleep duration is important for maintaining one’s physical and 
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mental health [9]. The National Sleep Foundation recommends 
appropriate sleep duration for all ages [10]. As described above, 
chronotype, SJL, and sleep duration are closely linked [11], imbal-
ances among them, including inadequate sleep duration, have 
been associated with increased risk for major chronic diseases, 
such as obesity, metabolic syndrome, and cardiovascular disease 
(CVD) [6,12-15].
High levels of triglycerides (TG) and low levels of high-density 
lipoprotein cholesterol (HDL-C) are major risk factors for CVD 
[16-18] and indicate plasma atherogenicity reflecting metabolic 
disruption and insulin resistance [19]. Several previous studies have 
established the impact of chronotype, SJL, and sleep duration on 
abnormal serum lipid levels [20,21], although their potential rela-
tionships have not been extensively investigated. Therefore, we 
aimed to determine the impact of chronotype, SJL and sleep du-
ration on atherogenic lipid profiles and which sleep-related pa-
rameter exhibits a stronger correlation with the atherogenicity. 
METHODS 
Study population
This study cross-sectional study initially included 2,168 adults 
who voluntarily attended the medical health check-up program 
from July 2016 to December 2016 in two tertiary medical institu-
tions (Severance check-up and Gangnam Severance check-up). 
The participants provided informed consent and responded to a 
questionnaire to determine study eligibility. We set the exclusion 
criteria as follows: 1) younger than 19 years of age, 2) missing data, 
and 3) incomplete questionnaire. 
Ultimately, data from 1,984 participants (19–81 years of age) 
were included in the final analysis. This study was conducted in 
accordance with the Declaration of Helsinki and was approved by 
the Institutional Review Board of Severance Hospital (IRB No. 3- 
2016-0123).
Covariates
Body weight and height were measured while participants wore 
light indoor clothing and no shoes. Body mass index (BMI) was 
calculated as body weight (kg) divided by height (m2). Systolic 
blood pressure (SBP) and diastolic blood pressure (DBP) were 
obtained from patients in the sitting position after a 10-min rest-
ing period. Mean arterial pressure (MAP) was calculated as 1/3 
SBP plus 2/3 DBP. Blood samples were collected from patients 
following an 8-hour fast. Serum glucose, total cholesterol (TC), 
TG, HDL-C, and low-density lipoprotein cholesterol (LDL-C) 
levels were measured with the ADVIA 1800 Clinical Chemistry 
System (Siemens Healthcare Diagnostics, Inc., Tarrytown, NY, 
USA). White blood cells (WBC) and 25-hydroxy vitamin D lev-
els were measured with the ADVIA 2120i Clinical Hematology 
System and the ADVIA Centaur XP Immunoassay System, re-
spectively (Siemens Healthcare Diagnostics, Inc.). The TC to 
HDL-C ratio was calculated as TC divided by HDL-C. Athero-
genic index of plasma (AIP) was calculated as the logarithmic ra-
tio of TG to HDL-C [17]. Individuals indicated if they took an an-
ti-dyslipidemia medication. Smoking status, alcohol intake, and 
physical activity were reported via a self-questionnaire. Smoking 
status was classified as never-smoker, ex-smoker, and current 
smoker. Alcohol intake was defined as consumption of alcohol 
greater than once per week. Physical activity was defined as exer-
cising more than three times a week with moderate to vigorous 
intensity. We screened for the presence of depression using Pa-
tient Health Questionnaire (PHQ)-9, which is composed of nine 
questions with answers on a 0 to 3 scale; a higher score indicates 
worse depressive symptoms [22]. 
Assessment of chronotype and sleep profiles
Chronotype was assessed by a Korean version of the Mornin-
gess–Eveningness Questionnaire (MEQ) originally developed by 
Horne and Ostberg [15,23]. The MEQ consists of 19 questions 
that assess habitual wakeup times and bed times and periods of 
best performances and feelings of well-being [23]. The question-
naire results are given as a numeric score ranging from 16 to 86. 
Higher MEQ scores are correlated with the early chronotype 
(“larks”). 
Participants then responded to the following questions: 1) “What 
is your average number of work days per week?”; 2) “What time 
do you usually wake up on work days?”; 3) “What time do you 
usually fall asleep work days?”; 4) “What time do you usually wake 
up on the free days?”; and 5) “What time do you fall asleep on free 
days?”. Midsleep on free days (MSF) and midsleep on workdays 
(MSW) were calculated as the mid-point between sleep onset and 
sleep offset on free days and workdays, respectively [5]. To re-
move the effect of sleep debt from SJL, we used the SJL corrected 
formula as follows according to Jankowski [7]:
SJLsc=|MSFsc-MSWsc|, 
where MSFsc=sleep onset on free days+half of the average week-
ly sleep duration; and MSWsc=sleep onset on workdays+half of 
the average weekly sleep duration.
Participants also indicated how many hours they slept on work 
days and on free days. Sleep duration was calculated as follows: 
(sleep duration of weekday×number of weekdays + sleep duration 
of free day×number of free days)/7.
Overall sleep quality was measured by the Pittsburgh Sleep Qual-
ity Index (PSQI) instrument [24]. The PSQI is a self-rated ques-
tionnaire that generates seven component scores: subjective sleep 
quality, sleep latency, sleep duration, habitual sleep efficiency, sleep 
disturbances, use of sleeping medication, and daytime dysfunc-
tion. The score of the answers is based on a 0 to 3 scale. A higher 
score indicates the worse quality of sleep, and a global PSQI score 
greater than 5 has a diagnostic value for poor sleep.
Statistical analyses 
Statistical analyses were performed using SPSS version 23.0 (IBM 
Corp., Armonk, NY, USA). Data are presented as the means± 
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standard deviations (SDs) or numbers (percentages). Simple Pear-
son’s correlation analyses were used to investigate correlations be-
tween MEQ score, SJL and sleep duration and clinical variables. 
Pearson’s partial correlation analyses were used to explore corre-
lations between MEQ score, SJL and sleep duration and clinical 
variables after adjusting for age, sex, and BMI. Differences in ab-
solute partial correlation coefficients and the dependency of two 
correlated correlation coefficients were evaluated using Steiger’s Z 
test [25]. To investigate the association between MEQ score, SJL 
and sleep duration and level of AIP, we stratified these values into 
tertiles (T) (MEQ score; T1: 16–46, T2: 47–55, T3: 56–86; SJL; T1: 
<30 min, T2: 31 min–1 h 30 min, T3: ≥1 h 31 min; sleep dura-
tion; T1: <6 h 38 min, T2: 6 h 39 min–7 h 30 min, T3: ≥7 h 31 min). 
Analysis of covariance was used to analyze associations be-
tween MEQ scores, SJL, and sleep duration and level of AIP after 
adjusting for age, sex and BMI. We used the Bonferroni post-hoc 
test to assess differences in AIP levels for each MEQ score, SJL, 
sleep duration tertile group. The stepwise and enter methods for 
multiple linear regression analyses were used to evaluate indepen-
dent associations between MEQ score, SJL, sleep duration and 
AIP after adjusting for age, sex, BMI, MAP, glucose level, WBC, 
smoking status, physical activity, alcohol consumption, and dys-
lipidemia medication. The level of statistical significance for all 
analyses was set as p<0.05.
RESULTS
Table 1 shows the clinical characteristics of the study popula-
tion. In total, 1,131 males (57%) and 853 females (43%) participat-
ed in this study. The mean age±SD and BMI±SD were 47.6±11.7 
years and 23.7±3.3 kg/m2, respectively. The levels of mean MEQ 
score, SJL, and sleep duration were 50.0±9.1, 1 h 15 min±1 h 16 
min, and 7 h 12 min±1 h 26 min, respectively. 
Table 2 shows relationships between MEQ score, SJL, sleep du-
ration and clinical variables. In the simple Pearson correlation, 
MEQ scores were significantly positively associated with age, BMI, 
MAP, glucose, HbA1c, and vitamin D (all p<0.01) but negatively 
associated with sex, PHQ-9 score, PSQI score, and HDL-C level (all 
p<0.01). Participant SJL was significantly positively associated with 
PHQ-9 score, PSQI score, and HDL-C level and negatively associ-
ated with age, BMI, and levels of serum glucose, HbA1c, and vita-
min D. Sleep duration was significantly negatively associated with 
age, BMI, and PSQI score. 
The partial Pearson’s correlation coefficients for MEQ score, SJL, 
sleep duration and lipid profiles are shown also in Table 2. After 
adjusting for age, sex, and BMI, we found significant associations 
between MEQ score, SJL, sleep duration and lipid profiles. MEQ 
score was significantly correlated with TG (r=-0.088, p<0.01), TC/ 
HDL (r=-0.059, p<0.05), and AIP (r=-0.089, p<0.01), while SJL was 
only significantly positively related with TC (r=0.055, p<0.05). 
Sleep duration was only significantly negatively related with HDL-
cholesterol (r=-0.053, p<0.01).
Table 3 shows the comparisons of correlation coefficients of 
MEQ score, SJL, sleep duration and lipid profiles. Partial Pearson’s 
correlation analysis showed that MEQ score was more highly as-
sociated with TG levels (r=-0.088) than with sleep duration ac-
cording to Steiger’s Z test (p=0.006). The analysis also showed that 
MEQ score was more strongly associated with AIP (r=-0.089) than 
with SJL and sleep duration (p=0.011 and p=0.031), respectively. 
Sleep duration was more highly associated with HDL-C (r=-0.053) 
than with SJL (p<0.001). 
Figure 1 presents the associations between MEQ score, SJL, and 
sleep duration tertile groups and AIP after adjusting for age, sex, 
and BMI. Values of AIP were significantly different among the 
MEQ score tertile groups; for example, the highest MEQ score 
tertile group had a significantly lower level of AIP compared to 
Table 1. General characteristics of study participants
Variables Values
Total participants, n 1,984
Sex
Male 1,131 (57.0)
Female 853 (43.0)
Age 47.6±11.7
Body mass index (kg/m2) 23.7±3.3
MAP (mm Hg) 91.1±11.4 
WBC (×109/L) 5.6±0.1
Vitamin D (ng/dL) 24.8±7.9
PSQI score 6.5±2.6
PHQ-9 score 4.1±3.9
Glucose (mg/dL) 99.5±18.2 
HbA1c (%) 5.5±0.7 
Triglycerides (mg/dL) 117.0±67.9
Total cholesterol (mg/dL) 198.8±35.7 
HDL-C (mg/dL) 54.2±12.7
LDL-C (mg/dL) 116.4±32.8 
TC/HDL 3.8±1.0
AIP 0.28±0.29
MEQ score 50.0±9.1
Social jetlag (corrected) 1 h 15 min±1 h 16 min
Sleep duration 7 h 12 min±1 h 26 min
Smoking
Non-smoker 1,107 (55.8)
Ex-smoker 518 (26.1)
Current smoker 359 (18.1)
Alcohol drinker
Yes 1,242 (62.6)
Physical activity
Yes 939 (47.3)
Dyslipidemia medication
Yes 225 (11.3)
Data are presented as mean±standard deviations or numbers (%). MAP: 
mean arterial pressure, WBC: white blood cell count, PSQI: Pittsburgh 
Sleep Quality Index, PHQ-9: Patient Health Questionnaire-9, MEQ: Morn-
ingness–Eveningness Questionnaire, HDL-C: high-density lipoprotein-
cholesterol, LDL-C: low-density lipoprotein-cholesterol, AIP: athero-
genic index of plasma, TC: total cholesterol, TC/HDL: TC divided by 
HDL, AIP: log (TG/HDL).
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the lowest MEQ tertile group (T3: 0.266 vs. T1: 0.298, p=0.002) 
(Figure 1A). We observed no significant differences in AIP among 
the SJL and sleep duration tertile groups (Figure 1B and C). 
Table 4 shows the independent association of MEQ score and 
AIP using multivariate adjusted models for multiple linear regres-
sion analysis, which identified MEQ score as a significant inde-
pendent factor associated with AIP (β=-0.001, p=0.038) accord-
ing to stepwise analysis. The enter method for multiple linear 
regression revealed a significant association between MEQ scores 
and AIP after adjusting for age, sex, BMI, MAP, glucose level, 
WBC, smoking status, physical activity, alcohol consumption, and 
dyslipidemia medication (β=-0.002, p=0.009). 
DISCUSSION 
In the current study, we found that MEQ score is significantly 
negatively correlated with AIP after adjusting for confounders and 
is more strongly correlated with AIP than with SJL and sleep du-
ration. This finding suggests that an individual’s chronotype could 
be more robustly related to an increased risk of atherosclerotic 
CVD (ASCVD) than SJL and sleep duration. Our study’s results 
corroborate those from previous studies, which have established 
that late chronotype is associated with type 2 diabetes [26], meta-
bolic syndrome [15], hypertension [27], and mortality [28]. Knut-
son and von Schantz [28], for the first time, reported that those 
with the late chronotype have an increased risk of mortality (haz-
ard ratio 1.10, 95% confidence interval 1.02–1.18) in a prospective 
study. Reutrakul et al. [26] showed that the late chronotype is also 
associated with worse glycemic control in type 2 diabetes patients, 
independent of subjective sleep debt, insufficient sleep duration, 
and sleep quality. Moreover, Osonoi et al. [29] reported that type 2 
Table 3. Comparison between correlation coefficients for sleep pa-
rameters and lipid profile data
r value p value§ p valueǁ
Triglycerides
MEQ -0.088 <0.001 Ref *
SJL 0.044 0.050 0.106
Sleep duration -0.002 0.930 0.006
Total cholesterol
MEQ -0.031 0.168 0.378
SJL 0.055 0.014 Ref †
Sleep duration -0.030 0.182 0.409
HDL-cholesterol
MEQ 0.035 0.115 0.569
SJL 0.041 0.069 <0.001
Sleep duration -0.053 0.019 Ref ‡
TC/HDL
MEQ -0.059 0.009 Ref *
SJL 0.007 0.739 0.056
Sleep duration 0.026 0.251 0.296
AIP
MEQ -0.089 <0.001 Ref *
SJL 0.020 0.383 0.011
Sleep duration 0.021 0.351 0.031
Presented r values are partial correlation coefficients between sleep pa-
rameters and lipid profile data after adjusting for age, sex, and body mass 
index. *R between MEQ score and lipid profile data are reference val-
ues, †R between SJL and total cholesterol are reference values, ‡R be-
tween sleep duration and HDL-cholesterol are reference values, §p val-
ues for r between each sleep parameter and lipid profile data, ǁp values 
from comparisons of absolute correlation coefficients using Steiger’s Z 
test between each sleep parameter and lipid profile data. MEQ: Morn-
ingness–Eveningness Questionnaire, HDL: high-density lipoprotein, 
SJL: social jetlag, TC: total cholesterol, TC: total cholesterol, AIP: ath-
erogenic index of plasma.
Table 2. Correlation between sleep parameters and clinical variables
Variables MEQ score SJL Sleep duration MEQ score† SJL† Sleep duration†
Age 0.466** -0.344** -0.47* - - -
Sex -0.108** 0.028 0.049* - - -
BMI 0.125** -0.048* -0.098** - - -
MAP 0.171** -0.040 -0.014 0.067** 0.035 0.038
Glucose 0.088** -0.050* -0.004 -0.052* 0.032 0.042
HbA1c 0.113** -0.098** 0.008 -0.063* 0.026 0.047
WBC -0.027 -0.007 0.006 -0.055* -0.025 0.040
Vitamin D 0.187** -0.169** -0.003 0.059* -0.088** 0.012
PHQ-9 -0.272** 0.121** 0.017 -0.208** 0.059* -0.011
PSQI -0.178** 0.109** -0.141** -0.181** 0.102** -0.151**
Triglyceride -0.014 0.019 -0.042 -0.088** 0.044 -0.002
Total cholesterol -0.009 0.041 -0.041 -0.031 0.055* -0.030
HDL-C -0.073** 0.078** 0.002 0.035 0.041 -0.053**
LDL-C 0.012 0.024 -0.021 -0.030 0.045 0.011
TC/HDL 0.041 -0.032 -0.023 -0.059* 0.007 0.026
AIP 0.002 -0.018 -0.003 -0.089** 0.020 0.021
Presented r values are simple Pearson’s correlation coefficients between sleep parameters and lipid profile data. *p<0.05 and **p<0.01, †Presented 
r values are partial correlation coefficients after adjusting for age, sex, and body mass index. MAP: mean arterial pressure, WBC: white blood cell 
count, PSQI: Pittsburgh Sleep Quality Index, PHQ-9: Patient Health Questionnaire-9, MEQ: Morningness–Eveningness Questionnaire, SJL: social 
jetlag, HDL-C: high-density lipoprotein-cholesterol, LDL-C: low-density lipoprotein-cholesterol, AIP: atherogenic index of plasma. 
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diabetes patients with the late chronotype had significantly high 
levels of TG, glucose, and HbA1c and low levels of HDL-C com-
pared with those with the early chronotype.
In the presence of excessive insulin, hypertriglyceridemia is a 
characteristic feature [30], as insulin suppresses lipolysis by inhib-
iting hormone-sensitive lipase activity and causing TG accumula-
tion in adipose tissue [31]. Insulin also inhibits the transfer of TG 
to ApoB, which leads to overproduction of very low-density lipo-
protein (VLDL) in the liver [30]. Hypertriglyceridemia also stim-
ulates an increase of TG-enriched HDL and LDL; the former is 
easily catabolized and results in reduced serum HDL levels, while 
the latter becomes small, dense LDL through hydrolysis via lipo-
protein lipase. 
Circadian misalignment often leads to SJL [7], which many re-
searchers have found is associated with cardiometabolic disor-
ders, such as obesity [6], diabetes [14] and dyslipidemia [32]. In 
our study, we found significant correlation only between SJL and 
TC after adjusting for age, sex, and BMI. Our findings show some 
discrepancy compared with those of previous studies. Wong et al. 
[32] reported that SJL is significantly correlated with lower HDL, 
higher TG, and higher glucose. However, another population-
based study conducted in Germany found that SJL greater than 
2 h is significantly associated with high levels of glucose and a 
greater waist circumference but is not associated with serum 
HDL and TG levels [14]. 
Sleep duration is also important for maintaining an individual’s 
well-being and physical health [10]. In the current study, longer 
sleep duration was significantly correlated with lower HDL levels 
after adjusting for age, sex, and BMI (r=-0.053, p<0.01). The rela-
tionship between sleep duration and lipid profiles are inconclusive. 
A study in Taiwan [33] found that sleep duration was not related 
with high TG and low HDL levels, while another study identified 
a U-shaped association between sleep duration and serum HDL 
levels [34].
In the current study, we found that MEQ score is strongly cor-
related with AIP, which suggests that chronotype is associated with 
atherogenic lipid profiles that predispose individuals to ASCVD. 
Although the nature of the relationship between MEQ score and 
Table 4. Multiple linear regression analysis of MEQ score and AIP
Stepwise method Enter method
B SE p value*‡ B SE p value†‡
MEQ score -0.001 0.001 0.038 -0.002 0.001 0.009
Age - - - 0.001 0.001 0.115
Sex -0.101 0.014 <0.001 -0.095 0.014 <0.001
BMI 0.027 0.002 <0.001 0.026 0.002 <0.001
MAP - - - 0.001 0.001 0.164
Glucose 0.002 0.000 <0.001 0.002 0.000 <0.001
WBC 0.035 0.004 <0.001 0.035 0.004 <0.001
Smoking 0.039 0.009 <0.001 0.039 0.009 <0.001
Physical activity - - - -0.011 0.011 0.301
Alcohol drinking -0.028 0.012 0.022 -0.024 0.013 0.060
Dyslipidemia medication - - - -0.005 0.018 0.769
*p values were calculated by stepwise multiple linear regression analyses, †p values were calculated by the enter method of multiple linear regres-
sion analysis, ‡Model variables included age, sex, BMI, MAP, Glucose, WBC, smoking, physical activity, alcohol drinking, and dyslipidemia medi-
cation. MEQ: Morningness–Eveningness Questionnaire, AIP: atherogenic index of plasma, BMI: body mass index, MAP: mean arterial pressure, 
WBC: white blood cell count.
Figure 1. Associations between MEQ score (A), SJL (B), sleep duration (C), and AIP. *p<0.05. AIP: Atherogenic index of plasma, MEQ: 
Morningness–Eveningness Questionnaire, SJL: social jetlag, T: Tertile.
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AIP is unclear, some evidence supports our present findings. First, 
light exposure at night disrupts energy metabolism, such as glu-
coneogenesis and lipogenesis, and leads to increased risk of met-
abolic syndrome and obesity [35,36]. Prolonged light exposure 
also increases inflammation, which has a strong link to cardiomet-
abolic disease [35]. Late chronotypes are prone to artificial light 
exposure late at night. Relatedly, Nimitphong et al. [37] reported 
that the late chronotype is associated with higher level of C-re-
active protein, a standard marker of systemic inflammation. Dur-
ing inflammation, pro-inflammatory cytokines, including TNF, 
IL-1, and IL-6, which alter lipid metabolism [38], are produced. 
Inflammation also leads to increased TG, VLDL, and small, dense 
LDL and decreased HDL. 
Second, circadian clocks are principal regulators of lipid absorp-
tion, metabolism, and transport [39]. In an animal study, mice with 
mutated clock genes developed hypertriglyceridemia [40]. In the 
peripheral clock, liver oscillation is more sensitive to feeding time 
than other zeitgebers [39], and night-restricted feeding shifts the 
phase of TG accumulation and reduced hepatic TG levels in mice 
[41].
Juda et al. [42] found that chronotype modulates sleep duration 
and sleep quality. Regarding SJL, several studies have suggested 
that weekend “catch-up sleep” may attenuate the undesirable ef-
fects of the late chronotype and substantial SJL [43,44]. Numer-
ous studies have established that U-shaped association between 
sleep duration and cardiometabolic risks, but statistical approach-
es such as correlation and regression analyses may be insufficient 
to fully characterize the relationship between sleep duration and 
continuous variables that compose lipids profiles. Therefore, clari-
fying the association between catch-up sleep and metabolic dis-
orders in future studies is needed.
Our study has several limitations. First, sleep-related indicators 
were assessed by self-reported questionnaires. Thus, we could not 
verify actual sleep time or exact MSW and MSF. Discrepancies in 
actual midsleep time and sleep duration may have been present. 
Further study using objective tools, such as actigraphy, is needed. 
Second, we could not consider all possible confounders, includ-
ing dietary factors (e.g., meal time and dietary intake). Third, the 
study lacked information regarding actual light exposure time. 
Despite of these limitations, the strength of our study is that, for 
the first time, we have revealed strong relationships between sleep 
parameters (chronotype, SJL, and sleep duration) and AIP. 
In conclusion, we found that the late chronotype is indepen-
dently and negatively associated with AIP, which is a valuable 
marker for predicting CVD. Furthermore, we clarified that chro-
notype is more strongly correlated with AIP than with SJL and 
sleep duration. Chronotherapeutic medicine, such as light thera-
py and sleep phase advance, could be beneficial for reducing in-
cidence of CVD in individuals with the late chronotype. 
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